BL
$15.81
+0.21
(+1.35%)
As of Oct 22, 2026, 9:28 PM EDT · cached
Price history
BlossomHill Therapeutics (BLSM) is trading up at $15.81 (+1.35%), as of the latest quote. It operates in the sector.
IPO: August 4, 2026 · $16.00 offering · Nasdaq · View IPO details →
BlossomHill Therapeutics net income history
Net income
| Q1 FY25†Mar 2025 | Q2 FY25Jun 2025 | Q1 FY26†Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|
| Income statement | ||||
| Operating income | −$11.5M | −$14.1M | −$22.1M | −$24.7M |
| Net income | −$10.5M | −$13.2M | −$21.0M | −$23.8M |
| EPS (diluted) | −$4.39 | −$5.51 | −$8.16 | −$8.75 |
| Balance sheet | ||||
| Cash and equivalents | — | $79.1M | — | $95.4M |
| Total assets | — | — | — | $124.1M |
| Total liabilities | — | — | — | $42.1M |
| Shareholders' equity | −$83.1M | −$96.0M | −$152.1M | −$174.8M |
From BlossomHill Therapeutics's 10-Q filings with the SEC. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
